Uveal melanoma day : 4th edition
The SIRIC brought together the uveal melanoma community (ophthalmologists, surgeons, oncologists, radiotherapists, researchers, etc.) for the 4th consecutive year at Institut Curie on 7 January 2022. Given the context, the day was once again held online.
The objectives of these patient days is to i) inform you about uveal melanoma ii) present the results of the latest clinical trials iii) show the results of our research work iv) show you how your biological samples and your generosity are helping to advance research.
The creation of spaces for dialogue between patients, doctors and researchers is a crucial step in the health democracy of research and care. Through these meeting days, we also want to give you a voice in order to better understand your expectations and, if possible, adapt research and care.
Watch the prestations
The presentations are accessible via the below player. You can also go directly to the presentation that you're interested in by clicking one of the following links. Please note that all of the presentations are in French.
- Introduction
Dr Manuel Rodrigues - Uveal melanoma, why me? Genetics of BAP1 and MBD4 syndromes
Dr Chrystelle Colas - Uveal melanoma, why me? Genetics of "low risk"
Dr Marc-Henri Stern - Ocular treatment of uveal melanoma
Dr Denis Malaise - Clinical trials: what is a clinical trial ?
Dr Alexandre de Moura - Clinical trials: results of recent trials of which ésultats tebentafusp and future trials
Dr Sophie Piperno-Neumann - Human and social sciences: improve communication and quality of life
Aude Rault - Presentation of the ANPACO association
Josette Dellis, president and founder of ANPACO
